Drugs / BioDFence G3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05363644 | Apr → Dec 2023 | prostate cancer | AdventHealth | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioDFence G3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05363644 ↗ |
| Route | Other | “BioDFence® G3 will be placed on the neurovascular bundles by the surgeon during the robotic assisted radical prostatectomy procedure” NCT05363644 ↗ |